Lung Cancer News

About 15% of a large cohort of patients with lung cancer had pathogenic germline variants, nearly all of which could be clinically actionable, according to study results presented during an ASCO Plenary Series session.

Sublobar resection conferred similar survival outcomes as lobectomy among certain patients with non-small cell lung cancer, according to phase 3 study results.

Most women with lung cancer reported some degree of sexual dysfunction following diagnosis, according to study results presented during International Association for the Study of Lung Cancer World Conference on Lung Cancer.

A randomized phase 3 trial designed to evaluate canakinumab as adjuvant treatment for completely resected non-small cell lung cancer failed to meet its primary endpoint, according to the agent’s manufacturer.

The FDA granted accelerated approval to fam-trastuzumab deruxtecan-nxki for treatment of adults with HER2-mutated unresectable or metastatic non-small cell lung cancer.

The FDA approved capmatinib for treatment of certain adults with metastatic non-small cell lung cancer.

Cigarette smoking-attributable cancer deaths appeared associated with nearly 2.2 million person-years of life lost and $20.9 billion in lost earnings across the United States in 2019, according to study results.

Irinotecan liposomal injection as second-line treatment of small cell lung cancer failed to extend OS compared with topotecan, according to the agent’s manufacturer.

Residents of low area-level income and education areas had higher odds of having late-stage non-small cell lung cancer at diagnosis than residents of high area-level income and education areas, according to study results.

World Lung Cancer Day will be held Aug. 1.